Analyst highlights three overlooked software companies he says are undervalued despite strong demand for automation, ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter ...

Step back and the picture is clear: the Australian production industry is under pressure, but it’s also alive with ...

Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European ...

SEATTLE — Applications are open for the city of Seattle's 2026 Technology Matching Fund Grants. The community matching grants of up to $45,000 go to nonprofit organizations and community groups with ...

Agile has transformed the way technology organizations innovate. But in highly regulated industries such as insurance, ...

Step into the mesmerizing world of CGI art with Dawid Herda as he blends the surreal with the ordinary in an awe-inspiring ...

Disney CEO Bob Iger sketched out some of Disney+'s future product roadmap -- which could include games, commerce and AI user ...

Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – – Potential NDA ...

Q2 2026 Management View President and CEO Shawn Singh announced "another major milestone in our PALISADE program. The last patient completed the randomized double-blind portion of our PALISADE-3 Phase ...

Support und Foren rund um Linux, OpenSource und Freie Software. Angebote wie News, Berichte, Workshops, Tipps, Links und Kalender.

Stifel Nicolaus analyst Suthan Sukumar maintained a Buy rating on Kinaxis Inc today and set a price target of C$245.00. According to TipRanks, Sukumar is an analyst with an average return of -3.6% and ...